- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of frontline treatment approach on outcomes of myeloid blast phase CML ; volume:14 ; number:1 ; day:15 ; month:6 ; year:2021 ; pages:1-10 ; date:12.2021
Journal of hematology & oncology ; 14, Heft 1 (15.6.2021), 1-10, 12.2021
- Creator
-
Saxena, Kapil
Jabbour, Elias
Issa, Ghayas
Sasaki, Koji
Ravandi, Farhad
Maiti, Abhishek
Daver, Naval
Kadia, Tapan
DiNardo, Courtney D.
Konopleva, Marina
Cortes, Jorge E.
Yilmaz, Musa
Chien, Kelly
Pierce, Sherry
Kantarjian, Hagop
Short, Nicholas J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-021-01106-1
- URN
-
urn:nbn:de:101:1-2021100520023681079443
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Saxena, Kapil
- Jabbour, Elias
- Issa, Ghayas
- Sasaki, Koji
- Ravandi, Farhad
- Maiti, Abhishek
- Daver, Naval
- Kadia, Tapan
- DiNardo, Courtney D.
- Konopleva, Marina
- Cortes, Jorge E.
- Yilmaz, Musa
- Chien, Kelly
- Pierce, Sherry
- Kantarjian, Hagop
- Short, Nicholas J.
- SpringerLink (Online service)
Other Objects (12)
Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations
Author Correction: Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
STAT3-mediated therapy resistance of malignant stem cells in chronic myeloid leukemia (CML)
CML
ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia
Blast - T cell - interaction in pediatric acute myeloid leukemia
Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations
Author Correction: Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
STAT3-mediated therapy resistance of malignant stem cells in chronic myeloid leukemia (CML)
CML
ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia
Blast - T cell - interaction in pediatric acute myeloid leukemia
Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations
Author Correction: Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
STAT3-mediated therapy resistance of malignant stem cells in chronic myeloid leukemia (CML)
CML
ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia